Mirum Pharmaceuticals (MIRM) Insider Trading & Ownership $52.12 +0.19 (+0.37%) As of 11:02 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Mirum Pharmaceuticals (NASDAQ:MIRM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.87%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$74.70KNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$6.18M Get MIRM Insider Trade Alerts Want to know when executives and insiders are buying or selling Mirum Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MIRM Insider Buying and Selling by Quarter Mirum Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/3/2025Jolanda HoweSVPSell477$49.08$23,411.16 7/2/2025Jolanda HoweSVPSell564$48.25$27,213.00 3/17/2025Christopher PeetzCEOSell27,279$44.21$1,206,004.59 3/17/2025Jolanda HoweSVPSell57,606$44.35$2,554,826.10 3/17/2025Peter RadovichCOOSell7,879$44.21$348,330.59 3/4/2025Patrick J HeronDirectorBuy1,335$45.57$60,835.95 2/3/2025Christopher PeetzCEOSell9,102$48.22$438,898.44 2/3/2025Jolanda HoweSVPSell1,064$48.22$51,306.08 2/3/2025Peter RadovichCOOSell2,627$48.22$126,673.94 1/24/2025Christopher PeetzCEOSell6,837$47.92$327,629.04 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/24/2025Jolanda HoweSVPSell902$47.92$43,223.84 1/24/2025Peter RadovichCOOSell3,177$47.92$152,241.84 1/17/2025Joanne QuanInsiderSell6,969$45.86$319,598.34 1/7/2025Christopher PeetzCEOSell7,489$42.82$320,678.98 1/7/2025Jolanda HoweSVPSell750$42.82$32,115.00 1/7/2025Peter RadovichCOOSell1,998$42.82$85,554.36 11/14/2024Jolanda HoweSVPSell2,500$47.10$117,750.00 9/18/2024Patrick J HeronDirectorBuy115$37.40$4,301.00 9/6/2024Patrick J HeronDirectorBuy230$41.58$9,563.40 (Data available from 1/1/2013 forward) MIRM Insider Trading Activity - Frequently Asked Questions Who is on Mirum Pharmaceuticals' Insider Roster? The list of insiders at Mirum Pharmaceuticals includes Christopher Peetz, Eric Bjerkholt, Joanne Quan, Jolanda Howe, Lara Longpre, Michael G. Grey, Niall O'donnell, Pamela Vig, Patrick J Heron, Peter Radovich, and Saira Ramasastry. Learn more on insiders at MIRM. What percentage of Mirum Pharmaceuticals stock is owned by insiders? 22.87% of Mirum Pharmaceuticals stock is owned by insiders. Learn more on MIRM's insider holdings. Which Mirum Pharmaceuticals insiders have been buying company stock? The following insiders have purchased MIRM shares in the last 24 months: Eric Bjerkholt ($397,700.00), and Patrick J Heron ($4,101,480.20). How much insider buying is happening at Mirum Pharmaceuticals? Insiders have purchased a total of 168,358 MIRM shares in the last 24 months for a total of $4,499,180.20 bought. Which Mirum Pharmaceuticals insiders have been selling company stock? The following insiders have sold MIRM shares in the last 24 months: Christopher Peetz ($2,439,219.32), Joanne Quan ($319,598.34), Jolanda Howe ($3,068,379.52), Lara Longpre ($28,572.76), Michael G. Grey ($454,912.00), Pamela Vig ($1,039,006.00), Peter Radovich ($863,284.37), and Saira Ramasastry ($128,400.00). How much insider selling is happening at Mirum Pharmaceuticals? Insiders have sold a total of 206,531 Mirum Pharmaceuticals shares in the last 24 months for a total of $8,341,372.31 sold. Mirum Pharmaceuticals Key ExecutivesMr. Christopher Peetz (Age 45)Co-Founder, CEO and Director Compensation: $1.31M3 recent tradesMr. Peter Radovich M.B.A. (Age 46)Ph.D., COO & President Compensation: $881.8k3 recent tradesMr. Eric H. Bjerkholt M.B.A. (Age 64)Chief Financial Officer Compensation: $600.4kDr. Pamela Vig Ph.D. (Age 53)Chief Scientific Officer Compensation: $678.2kAndrew McKibbenVice President of Investor Relations and FinanceMr. Paul K. RossChief Compliance OfficerMs. Erin Campany (Age 56)Senior Vice President of Human Resources Ms. Lara Longpre MBA (Age 54)MSC, Chief Development Officer Compensation: $678.2kMs. Vinita P. KumarSenior vice President of QualityDr. Jean-Luc Girardet Ph.D.Senior Vice President of Technical Operations More Insider Trading Tools from MarketBeat Related Companies BridgeBio Pharma Insider Trading Verona Pharma PLC American Depositary Share Insider Trading Blueprint Medicines Insider Trading Roivant Sciences Insider Trading Elanco Animal Health Insider Trading Revolution Medicines Insider Trading Grifols Insider Trading TG Therapeutics Insider Trading Nuvalent Insider Trading Lantheus Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealth This page (NASDAQ:MIRM) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mirum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
